GenSci098

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GenSci098, covering 2026-02-11 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GenSci098 in Subjects With Active Thyroid Eye Disease [Phase 1]